Junya Makiyama

13PUBLICATIONS
43CO-AUTHORS
Haematological tumoursTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 21, 2025
A Multicenter Real-World Retrospective Study for Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, and Prednisolone for Previously Untreated Patients With CD30-Positive Adult T-Cell Leukemia-Lymphoma.

Masahito Tokunaga, Junya Makiyama, Motoaki Shiratsuchi

|Sep 02, 2025
Outcomes of patients aged 70 years or younger with aggressive ATL at core hospitals for ATL treatment in Tokyo.

Junya Makiyama, Nobuhiro Ohno, Koji Jimbo

|Feb 03, 2025
Significant detrimental impact of pre-transplant mogamulizumab on the post-transplant outcome with a short interval between the last mogamulizumab and transplantation.

Shigeo Fuji, Masahito Tokunaga, Koji Kato

|Feb 21, 2024
Mechanisms of action and resistance in histone methylation-targeted therapy.

Makoto Yamagishi, Yuta Kuze, Seiichiro Kobayashi

|Nov 21, 2023
Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

Michihiro Hidaka, Koiti Inokuchi, Nobuhiko Uoshima

|Aug 18, 2023
An update on the developments in the treatment of adult T-cell leukemia-lymphoma: current knowledge and future perspective.

Junya Makiyama, Kenji Ishitsuka, Wataru Munakata

Pageof 3

Frequent Collaborators

4 joint publications

Shigeo Fuji

2 joint publications

Makoto Onizuka

2 joint publications

Yoshiko Atsuta

2 joint publications

Satoko Morishima